Correlation Between Pfizer and 26442CBH6
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and DUK 355 15 MAR 52, you can compare the effects of market volatilities on Pfizer and 26442CBH6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 26442CBH6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 26442CBH6.
Diversification Opportunities for Pfizer and 26442CBH6
Poor diversification
The 3 months correlation between Pfizer and 26442CBH6 is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and DUK 355 15 MAR 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DUK 355 15 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 26442CBH6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DUK 355 15 has no effect on the direction of Pfizer i.e., Pfizer and 26442CBH6 go up and down completely randomly.
Pair Corralation between Pfizer and 26442CBH6
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 26442CBH6. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.07 times less risky than 26442CBH6. The stock trades about -0.3 of its potential returns per unit of risk. The DUK 355 15 MAR 52 is currently generating about -0.25 of returns per unit of risk over similar time horizon. If you would invest 7,293 in DUK 355 15 MAR 52 on August 27, 2024 and sell it today you would lose (514.00) from holding DUK 355 15 MAR 52 or give up 7.05% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 80.95% |
Values | Daily Returns |
Pfizer Inc vs. DUK 355 15 MAR 52
Performance |
Timeline |
Pfizer Inc |
DUK 355 15 |
Pfizer and 26442CBH6 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and 26442CBH6
The main advantage of trading using opposite Pfizer and 26442CBH6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 26442CBH6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 26442CBH6 will offset losses from the drop in 26442CBH6's long position.Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
26442CBH6 vs. Highway Holdings Limited | 26442CBH6 vs. Amgen Inc | 26442CBH6 vs. Electrovaya Common Shares | 26442CBH6 vs. CECO Environmental Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |